New Zealand markets open in 8 hours 3 minutes

Ono Pharmaceutical Co., Ltd. (ON4.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
12.50+0.10 (+0.81%)
As of 03:29PM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 6.00B
Enterprise value 4.87B
Trailing P/E 8.08
Forward P/E 13.50
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.06
Price/book (mrq)1.28
Enterprise value/revenue 1.68
Enterprise value/EBITDA 4.65

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-22.50%
S&P500 52-week change 325.51%
52-week high 318.20
52-week low 312.20
50-day moving average 312.98
200-day moving average 315.11

Share statistics

Avg vol (3-month) 357
Avg vol (10-day) 350
Shares outstanding 5469.65M
Implied shares outstanding 6483.88M
Float 8383.27M
% held by insiders 115.55%
% held by institutions 147.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.48
Forward annual dividend yield 43.88%
Trailing annual dividend rate 380.00
Trailing annual dividend yield 3645.16%
5-year average dividend yield 4N/A
Payout ratio 430.01%
Dividend date 3N/A
Ex-dividend date 427 Sept 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 25.46%
Operating margin (ttm)13.90%

Management effectiveness

Return on assets (ttm)11.16%
Return on equity (ttm)16.56%

Income statement

Revenue (ttm)502.67B
Revenue per share (ttm)1,047.21
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA 178.43B
Net income avi to common (ttm)127.98B
Diluted EPS (ttm)1.54
Quarterly earnings growth (yoy)2.10%

Balance sheet

Total cash (mrq)204.6B
Total cash per share (mrq)435.64
Total debt (mrq)8.86B
Total debt/equity (mrq)1.11%
Current ratio (mrq)3.99
Book value per share (mrq)1,688.42

Cash flow statement

Operating cash flow (ttm)110.66B
Levered free cash flow (ttm)50.1B